Results 71 to 80 of about 976,952 (369)

Estimating time-to-onset of adverse drug reactions from spontaneous reporting databases. [PDF]

open access: yes, 2014
International audienceBACKGROUND: Analyzing time-to-onset of adverse drug reactions from treatment exposure contributes to meeting pharmacovigilance objectives, i.e. identification and prevention. Post-marketing data are available from reporting systems.
A Bate   +42 more
core   +2 more sources

Pharmacological surveillance system in the Hospital of the University of Chile

open access: yesMedwave, 2011
Adverse drug reaction reporting systems, pharmaceutical services, pharmacovigilance, pharmacosurveillance.
Rodrigo Orellana
doaj   +1 more source

Dose‐dependent induction of epithelial‐mesenchymal transition in 3D melanoma models by non‐thermal plasma treatment

open access: yesMolecular Oncology, EarlyView.
Non‐thermal plasma treatment of melanoma cells induced epithelial‐mesenchymal transition (EMT) in a dose‐dependent fashion. This report highlights the critical need to further investigate potential adverse effects of non‐thermal plasma for cancer therapy and to optimize treatment parameters for clinical translation. Despite the promising results of non‐
Eline Biscop   +10 more
wiley   +1 more source

A National Adverse Drug Reaction Reporting System for Malta [PDF]

open access: yes, 2004
The mission of the Medicines Authority (MA) in Malta is to contribute to protection of public health through regulation of the safety, quality and efficacy of medicines for human use on the local market and to ensure that healthcare professionals and ...
Arthur, Niamh   +2 more
core  

Big Data Transforms Discovery-Utilization Therapeutics Continuum. [PDF]

open access: yes, 2016
Enabling omic technologies adopt a holistic view to produce unprecedented insights into the molecular underpinnings of health and disease, in part, by generating massive high-dimensional biological data.
Alfirevic   +17 more
core   +2 more sources

The role of Clinical Pharmacists in the improvement of a pharmacovigilance system: A review of the reported adverse drug reactions during 2004-2010 in Mazandaran Province of Iran.

open access: yesJournal of Pharmaceutical Care, 2015
Background: Following establishment of Iranian Adverse Drug Reaction (ADR) Monitoring  Center  in  1997, ADR  committees  were  established  in  all  hospitals  of Mazandaran Province of Iran.
Ebrahim Salehifar   +4 more
doaj  

Adverse Drug Reactions Relevant to Drug Resistance and Ineffectiveness Associated with Meropenem, Linezolid, and Colistin: An Analysis Based on Spontaneous Reports from the European Pharmacovigilance Database

open access: yesAntibiotics, 2023
Antimicrobial resistance is considered one of the major threats to public health and is an important factor that influences the patient’s outcome in the intensive care unit.
Bogdan Ioan Vintila   +8 more
doaj   +1 more source

Beyond digital twins: the role of foundation models in enhancing the interpretability of multiomics modalities in precision medicine

open access: yesFEBS Open Bio, EarlyView.
This review highlights how foundation models enhance predictive healthcare by integrating advanced digital twin modeling with multiomics and biomedical data. This approach supports disease management, risk assessment, and personalized medicine, with the goal of optimizing health outcomes through adaptive, interpretable digital simulations, accessible ...
Sakhaa Alsaedi   +2 more
wiley   +1 more source

Adverse drug reactions reported by consumers for nervous system medications in Europe 2007 to 2011 [PDF]

open access: yesBMC Pharmacology and Toxicology, 2013
Abstract Background Reporting of adverse drug reactions (ADRs) has traditionally been the sole province of healthcare professionals. In the European Union, more countries have allowed consumers to report ADRs directly to the regulatory agencies.
Aagaard, Lise, Hansen, Ebba Holme
openaire   +5 more sources

Occurrence and Preventability of Adverse Drug Events in Hospitalized Patients: A Systematic Review [PDF]

open access: yes, 2018
Patient safety is now recognized as a priority by health systems around the world, drug-related problem is one of the component for patient safety assessment.
., Suherman, Nurwahyuni, A
core   +2 more sources

Home - About - Disclaimer - Privacy